Day: October 3, 2024

Newly created foundation will provide grants to support nonprofit charitable organizations that align with HealthEquity’s mission, vision, and values DRAPER, Utah, Oct. 03, 2024 (GLOBE NEWSWIRE) — HealthEquity, Inc. (Nasdaq: HQY) (“HealthEquity”), the leader in Health Savings Account (HSA) and consumer-directed benefits administration, today announced the launch of its new HealthEquity Community Foundation. Dedicated to building healthcare literacy and confidence in communities across the United States, the Foundation’s initial focus will be on providing grants to nonprofit charitable organizations. “For over two decades, HealthEquity teammates have worked with nonprofit charitable organizations and businesses to make a real difference in the communities where we live and work. Now, with the launch of the HealthEquity...

Bollinger B4 Truck Delivery to Nacarato Truck Centers in LaVergne, TennesseePictured (left to right): Patrick Daily of Nacarato Truck Centers and Jim Connelly of Bollinger Motors.Nacarato Operates 13 Locations Throughout the East, Southeast and MidwestPictured (left to right): Kevin Lowry, Scott Shipp, Patrick Daily, Jim Connelly and Sawyer SparksFirst deliveries of Bollinger B4 electric trucks to Nacarato Truck Centers with a value of $800,000  First revenue recognized for three months ended Sept. 30, 2024, with wire transfer payment received on Sept. 30, 2024 BREA, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) — via IBN – Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an electric vehicle (“EV”) manufacturer, announces today that its subsidiary, Bollinger Motors (“Bollinger”), has made the first...

HERNDON, Va., Oct. 03, 2024 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI) has been recognized for the third year as a Best Place to Work for Working Daughters, according to Working Daughter, a community for women balancing eldercare with their careers. The annual list recognizes companies that support family caregivers and also raises awareness of how businesses help make caregiving and professional success compatible. “The companies on this list understand that supporting working caregivers is a business imperative,” said Liz O’Donnell, Working Daughter founder. “While many companies have established initiatives to assist employees who are parents, it is equally critical to acknowledge and support employees who are caring for aging parents and other adult family members.” Working Daughter finds that more than one in six working...

BlackLine’s comprehensive platform and customer-centric innovation recognized by leading global analyst firm LOS ANGELES, Oct. 03, 2024 (GLOBE NEWSWIRE) — BlackLine, the future-ready platform for the Office of the CFO, today announced it has been named a Leader in IDC MarketScape: Worldwide Office of the CFO Record to Report 2024 Vendor Assessment (doc # US52037924, September 2024). The IDC MarketScape report highlights the critical role of the record-to-report (R2R) process in ensuring accurate financial reporting and compliance, emphasizing its importance for CFOs, investors, and shareholders. The report evaluated nine vendors based on their capabilities to support the R2R process. According to IDC analysis, buyer perception, and end-user feedback, BlackLine was positioned in the Leaders Category. According to the IDC MarketScape,...

CINCINATTI, Oh., Oct. 03, 2024 (GLOBE NEWSWIRE) — Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or “the Company”) (formerly Blue Water Biotech, Inc. (BWV)), a cancer diagnostics company focused on the research, development and commercialization of innovative solutions for oncology, today announced the signing and closing of a private placement of (i) 3,499 shares of the Company’s Series C Convertible Preferred Stock, $0.00001 par value (the “Series C Preferred Stock”), and (ii) warrants (the “Warrants”) to acquire up to an aggregate of 591,856 additional shares of the Company’s common stock, $0.00001 par value per share (the “Common Stock”), for aggregate gross proceeds of approximately $2.0 million. The Series C Preferred Stock are initially convertible into an aggregate of 776,590 shares of Common Stock, subject to certain anti-dilution...

Del’s Mucho Meal$™, starting at just $4.49, offer guests more food and more flavor for less. Plus, the Cookie Butter Shake, made with real Biscoff® cookies, is back!Snack Taco Mucho Meal$4.49 Snack Taco Mucho Meal: For the taco fans, get 2 Snack Tacos, a Mini Cinnamon Churro, small Crinkle Cut Fries, and a 16oz Fountain Drink for only $4.49!B&C Burrito Mucho Meal$5.49 B&C Burrito Mucho Meal: Grab 2 of our favorites! A Bean & Cheese Burrito with a choice of red or green sauce, a Grilled Chicken Taco, a Mini Cinnamon Churro, small Crinkle Cut Fries, and a 16oz Fountain Drink for only $5.49!Double Taco Mucho Meal$6.49 Double Taco Mucho Meal: Enjoy our Double Taco Mucho Meal with a The Del Taco, a Grilled Chicken Taco, a Mini Cinnamon Churro, small Crinkle Cut Fries, and a 16oz Fountain Drink...

Highlights include increased ARAKODA® (tafenoquine) brand awareness and utilization through virtual sales outreach using digital behavioral analytics and a co-pay program to assist consumers with out-of-pocket costs. ARAKODA is the only new antimalarial in over a decade and is differentiated by a broad efficacy against all malaria stages, a convenient weekly dosing schedule, and a well-established safety profile.WASHINGTON, Oct. 03, 2024 (GLOBE NEWSWIRE) — 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that the Company has commenced a nine-month promotional pilot to bring greater awareness of ARAKODA® (tafenoquine) and its benefits to patients and healthcare providers who prescribe it. ARAKODA (tafenoquine)...

SCOTTSDALE, Ariz., Oct. 03, 2024 (GLOBE NEWSWIRE) — Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that members of Journey Medical’s management team will attend one-on-one meetings at the 3rd Annual ROTH Healthcare Opportunities Conference, scheduled to take place on Wednesday, October 9, 2024 in New York City. About Journey Medical CorporationJourney Medical Corporation (Nasdaq: DERM) (“Journey Medical”) is a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products...